Contributed equally as first authors.
Translational and Clinical Research
Article first published online: 16 NOV 2011
Copyright © 2011 AlphaMed Press
Volume 29, Issue 12, pages 2077–2089, December 2011
How to Cite
Liu, Y., Jiang, X., Zhang, X., Chen, R., Sun, T., Fok, K. L., Dong, J., Tsang, L. L., Yi, S., Ruan, Y., Guo, J., Yu, M. K., Tian, Y., Chung, Y. W., Yang, M., Xu, W., Chung, C. M., Li, T. and Chan, H. C. (2011), Dedifferentiation-Reprogrammed Mesenchymal Stem Cells with Improved Therapeutic Potential. STEM CELLS, 29: 2077–2089. doi: 10.1002/stem.764
Author contributions: Y.L. and X.Z.: collection and/or assembly of data, data analysis and interpretation, manuscript writing, and final approval of manuscript; X.J.: design, collection and/or assembly of data, data analysis and interpretation, manuscript writing, and final approval of manuscript; R.C., T.S., K.L.F., J.D., L.L.T., S.Y., Y.R., J.G., M.K.Y., Y.T., and W.X.: collection and/or assembly of data, data analysis and interpretation, and final approval of manuscript; Y.W.C.: collection and/or assembly of data, data analysis and interpretation, administrative support, and final approval of manuscript; M.Y.: data analysis and interpretation, provision of study material, and final approval of manuscript; C.M.C.: collection and/or assembly of data and data analysis and interpretation, T.L.: conception and design, financial support, provision of study material, data analysis and interpretation, and final approval of manuscript; H.C.C: conception and design, financial support, provision of study material, data analysis and interpretation, manuscript writing, and final approval of manuscript.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLSEXPRESS November 3, 2011.
- Issue published online: 16 NOV 2011
- Article first published online: 16 NOV 2011
- Accepted manuscript online: 3 NOV 2011 08:50AM EST
- Manuscript Accepted: 27 SEP 2011
- Manuscript Received: 25 JAN 2011
- Focused Investment Scheme and Li Ka Shing Institute of Health Sciences of the Chinese University of Hong Kong
- Morningside Foundation
- National Natural Science Foundation of China (. Grant Numbers: 30830106, 30872670, 81100475
- National Basic Research Program of China. Grant Number: 012CB944900
- Fundamental Research Funds for the Central Universities (Jinan University)
- Chinese University of Hong Kong. Grant Numbers: 2009.1.071, 2010.1.016
- Hong Kong University Grants Committee. Grant Numbers: GRF2010/2011, CUHK466710
- NSFC grant. Grant Number: 31140034
Additional Supporting Information may be found in the online version of this article.
|STEM_764_sm_supplFigure1.TIF||434K||S1: Schematic illustration of the experimental design and beneficial effects of De-MSCs in HIBD model.|
|STEM_764_sm_supplFigure2.TIF||1703K||S2: Neuronal differentiation of MSCs in vitro. Monoclonal MSCs (clone 3) were plated at 10x102/cm2 in 6 well plates and neuronal differentiation was performed as described in Materials and Methods. a: Phase contrast photographs of neuronal differentiation at different time points (24-72 hours). scale bar= 100μm b: RT-PCR analysis for selected markers of lineage commitment at successive time-points of MSC differentiation. c-f: Quantitative analysis of b, data were from three independent experiments. **, p<0.01; ***, p<0.001.|
|STEM_764_sm_supplFigure3.TIF||1683K||S3: Different clones of MSCs showed the same enhanced neuronal potential and survival after dedifferentiation process. Monoclonal MSCs (clone 1, 2, 3, 5) were plated at 10x102/cm2 in 6 well plates and neuronal differentiation (24 hours), dedifferentiation (24 hours) and re-differentiation (24 hours) were performed as described in Materials and Methods. a: Flow cytometry analysis of MSCs (clone 1 and clone 2) showing similar stem cell surface markers. b: Phase contrast photographs of neuronal differentiation, dedifferentiation and re-differentiation of clone 1 and clone 2 MSCs □scale bar= 100μm. c: Immunostaining of the general neuronal markers, NF-M during neuronal differentiation, dedifferentiation and re-differentiation process for clone 2 MSCs. (Scale bar=100μm). d: Quantification analysis showing enhanced neuronal differentiation after dedifferentiation process in different clones. *, p<0.05; **, p<0.01. e: MTT analysis showing enhanced cell survival upon different concentration of H2O2 in dedifferentiated clone 2 MSCs, *, p<0.05.|
|STEM_764_sm_supplFigure4.TIF||840K||S4: Concomitant upregulation and reversion of multiple neurogenesis marker genes as determined by PCR array focused on neurogenesis and neural stem cells (Qiagen, PARN-404c). The expression levels of multiple neurogenesis genes were markedly increased in differentiated cultures (24 hours) compared with undifferentiated MSCs. In addition, dedifferentiation (24 hours) from the neuronal to the stem cell phenotype was associated with a marked reduction in the expression of neuronal markers. Furthermore, De-MSCs could undergo redifferentiation (24 hours) with full expression of the neuronal markers, indicating an enhanced neuronal potential in De-MSCs.|
|STEM_764_sm_supplFigure5.TIF||665K||S5: Molecular characterization of De-MSCs. a: RT-PCR analysis confirmed the expression profiles of some altered genes indicated in the genome microarray. b: Immunofluoresence staining of Tri-Methyl-H3K4 and Tri-Methyl-H3K27 in MSCs, MSC-differentiated neurons and De-MSCs, with corresponding DAPI staining and merged images (scale bar= 30 μm).|
|STEM_764_sm_supplFigure6.TIF||813K||S6: Enhanced cell proliferation was not retained in De-MSCs after passaging. a: Representative immunofluorescence staining of PCNA. 1x104 MSCs or De-MSCs at passage 2 (5 days after dedifferentiation) were seeded on individual coverslide in 6 well plate. 24 hours after, the cells were stained with PCNA as described in Materials and Methods, scale bar=100μm. b: Quantitative analysis of a, *, p<0.05. c: Flow cytometric analysis of cell cycle progression in MSCs and De-MSCs showing no significant difference between MSCs and De-MSCs cultured for 48hours.|
|STEM_764_sm_supplFigure7.TIF||1333K||S7: De-MSCs with advanced passage remained their advantage in cell survival and neuronal differentiation. a: Flow cytometry analysis of CD markers for De-MSCs at passage 3 (day 10 after dedifferentiation). (a'), CD34; (b'), CD45; (c'): CD29; (d'): CD90. b: MTT assay showing De-MSCs at passage 3 (day 10 after dedifferentiation) retained enhanced cell survival compared to undifferentiated MSCs. *, p<0.05; **, p<0.01. c: FACS analysis of Annexin- V/propidium iodide-stained cells in MSCs and De- MSCs at passage 3 (p3, day 12 after dedifferentiation) challenged with 250μM H2O2 in media containing 0.5% FBS for 24 hours. Primary FACS plots were shown in the upper panel (a': MSCs; b': MSCs with H2O2; c': De-MSCs p3; d': De-MSCs p3 with H2O2) and quantifications from two independent experiments were shown in the lower panel **, p<0.01. d: Immunofluoresence staining of NF-M in MSCs, De-MSCs at passage 3 (day 12 after dedifferentiation), and De-MSCs (p3) induced reneuron with corresponding DAPI staining and merged images (scale bar= 100 μm).|
|STEM_764_sm_supplFigure8.TIF||393K||S8: MSCs and De-MSCs (24 hours after dedifferentiation) were serum starved for 24 hours and changes of bcl-2 family proteins were detected by western blot.|
|STEM_764_sm_supplFigure9.TIF||2003K||S9: Phase contrast images showing that some MSCs and De-MSCs (24 hours after dedifferentiation) rapidly transformed from fibroblastic to neuronal morphology 24 hours after co-culture with H2O2 treated PHN.|
|STEM_764_sm_supplFigure10.TIF||1530K||S10: Immunohistochemical staining of MAP2 on day 3 or day 7 brain sections of HIBD rat implanted with MSCs or De-MSCs (24 hours after dedifferentiation) (scale bar=20μm).|
|STEM_764_sm_supplFigure11.TIF||397K||S11: Schematic illustration of the shuttle box test.|
|STEM_764_sm_supplFigure12.TIF||277K||S12: Gene ontology analysis showing significantly different biological processes between De-MSCs (24 hours after dedifferentiation) and MSCs treated HIBD brains. One week after transplantation, the HIBD brains were collected and RNA was extracted and hybridized on Agilent whole rat genome oligo microarray as described in Materials and Methods.|
|STEM_764_sm_supplTable1.pdf||58K||Supplementary Table 1|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.